Comparison of the uptake of untargeted and targeted immunostimulatory nanoparticles by immune cells in the microenvironment of metastatic breast cancer
Gil Covarrubias, Taylor J. Moon, Georgia Loutrianakis, Haley M. Sims, Mayura P. Umapathy, Morgan E. Lorkowski, Peter A. Bielecki, Michelle L. Wiese, Prabhani U. Atukorale, Efstathios Karathanasis
Abstract
integrin and P-selectin that are commonly used to direct nanoparticles to tumors. Using the 4T1 mouse model, we assessed the microdistribution of the four NP variants in the tumor immune microenvironment in three different breast cancer landscapes, including primary tumor, early metastasis, and late metastasis. The different NP variants resulted in variable uptake by immune cell subsets depending on the organ and tumor stage. Among the NP variants, therapeutic studies indicated that the untargeted NPs and the integrin-targeting NPs exhibited a remarkable short- and long-term immune response and long-lasting antitumor effect.